Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
12-16 September, 2025
SCI Medicinal Chemistr...SCI Medicinal Chemistry
Not Confirmed
Not Confirmed
14-17 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
12-16 September, 2025
SCI Medicinal Chemistr...SCI Medicinal Chemistry
Industry Trade Show
Not Confirmed
14-17 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129134/0/en/Intellia-Therapeutics-Announces-Second-Quarter-2025-Financial-Results-and-Highlights-Recent-Company-Progress.html
01 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/01/3125715/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
31 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/31/3124878/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-Second-Quarter-2025-Earnings-and-Company-Updates.html
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3111290/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
15 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/15/3099489/0/en/Intellia-Therapeutics-Announces-Positive-Three-Year-Data-from-Phase-1-Trial-of-Lonvoguran-Ziclumeran-lonvo-z-in-Patients-with-Hereditary-Angioedema-HAE-at-the-European-Academy-of-A.html
05 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/05/3094754/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE